Clinical Trial

Control of Assistive Devices Via Brain-Computer Interface Technology

Study acronym: CONVOY
Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
The CONVOY Study is a clinical trial designed to explore the feasibility of participants from the PRIME Study (NCT06429735) using the N1 Implant to control various assistive devices. The main goal is to determine whether participants can successfully modulate their brain activity to control devices, such as an Assistive Robotic Arm (ARA). This study will assess the effectiveness, consistency, and safety of neural control using the ARA and other assistive devices.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-11-26.
Trial Details
NCT Number NCT06710626
Lead Sponsor Neuralink Corp
Conditions Tetraplegia/Tetraparesis, Amyotrophic Lateral Sclerosis (ALS), Quadriplegia, Spinal Cord Injury (SCI), Spinal Cord Injury Cervical
Enrollment 3 participants
Start Date 2024-11-25
Primary Completion 2031-05-25 (estimated)
Study Completion 2031-05-25 (estimated)
Updated on ClinicalTrials.gov 2025-06-05